CURIS, INC. Other Comprehensive Income (Loss), Net of Tax
CURIS, INC. (CRIS) reported Other Comprehensive Income (Loss), Net of Tax of -$18.81 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2013-03-13
- CURIS, INC. other comprehensive income (loss), net of tax for fiscal 2012 was -$18.81K.
- CURIS, INC. other comprehensive income (loss), net of tax for fiscal 2011 was -$11.40K, a 125.48% decline from fiscal 2010.
- CURIS, INC. other comprehensive income (loss), net of tax for fiscal 2010 was $44.73K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|
| 2012-12-31 | -$18.81K 10-K · filed 2013-03-13 |
| 2011-12-31 | -$11.40K 10-K · filed 2013-03-13 |
| 2010-12-31 | $44.73K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |